Kiniksa Pharmaceuticals International, Plc

Contributing Author

Recent Articles by Kiniksa Pharmaceuticals International, Plc

Oct-28	Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution KNSA GlobeNewswire
Oct-23	Kiniksa Pharmaceuticals to Report Third Quarter 2025 Financial Results on October 28, 2025 KNSA GlobeNewswire
Oct-17	Kiniksa Pharmaceuticals Announces U.S. Orphan Drug Designation for KPL-387 for the Treatment of Pericarditis KNSA GlobeNewswire
Aug-28	Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences KNSA GlobeNewswire
Jul-29	Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution KNSA GlobeNewswire
Jul-24	Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025 KNSA GlobeNewswire